Underwater posterior nasal neurectomy compared to resection of peripheral branches of posterior nerve in severe allergic rhinitis

Makihara, Seiichiro; Okano, Mitsuhiro; Miyamoto, Syotaro; Uraguchi, Kensuke; Tsumura, Munechika; Kariya, Shin; Ando, Mizuo

doi:10.1080/00016489.2021.1925151

Cited by 6 publications

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Specifically, the PNN, a branch of the vidian, appears to be an appropriate target given its specific nasal innervation. Though there is no study that evaluates vidian and PNN neurectomy head‐to‐head in AR patients, PNN neurectomy has been similarly shown to be effective for reducing symptoms, 229,2374,2396–2401 though one non‐randomized controlled trial did not find a benefit to adding PNN neurectomy to microdebrider‐assisted turbinoplasty 2402 . Given the evidence, neurectomy is an option for treating refractory rhinorrhea following failed medical management (Tables XI.C.‐3 and XI.C.‐4).…”

Section: Managementmentioning

confidence: 99%

International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

Wise

Damask

Roland

et al. 2023

Int Forum Allergy Rhinol

151

View full text Add to dashboard Cite

Background In the 5 years that have passed since the publication of the 2018 International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis 2018), the literature has expanded substantially. The ICAR‐Allergic Rhinitis 2023 update presents 144 individual topics on allergic rhinitis (AR), expanded by over 40 topics from the 2018 document. Originally presented topics from 2018 have also been reviewed and updated. The executive summary highlights key evidence‐based findings and recommendation from the full document. Methods ICAR‐Allergic Rhinitis 2023 employed established evidence‐based review with recommendation (EBRR) methodology to individually evaluate each topic. Stepwise iterative peer review and consensus was performed for each topic. The final document was then collated and includes the results of this work. Results ICAR‐Allergic Rhinitis 2023 includes 10 major content areas and 144 individual topics related to AR. For a substantial proportion of topics included, an aggregate grade of evidence is presented, which is determined by collating the levels of evidence for each available study identified in the literature. For topics in which a diagnostic or therapeutic intervention is considered, a recommendation summary is presented, which considers the aggregate grade of evidence, benefit, harm, and cost. Conclusion The ICAR‐Allergic Rhinitis 2023 update provides a comprehensive evaluation of AR and the currently available evidence. It is this evidence that contributes to our current knowledge base and recommendations for patient evaluation and treatment.

show abstract

Section: Managementmentioning

confidence: 99%